Chroma Medicine
Cambridge
About Chroma Medicine
Chroma Medicine is a new genomic medicine company working on epigenetic editing. Chroma Medicine is pioneering a new class of genomic medicines that harness epigenetics, nature’s innate mechanism for gene regulation, to revolutionize the treatment of genetically driven diseases. Chroma Medicine was established in 2021 in Cambridge, Massachusetts.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $260.0M
- Funding stage: M&A
- Last round: Series B (Feb 2023)
- Website: chromamedicine.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/chroma-medicine-56881 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.